Prescribing Non-Opioid Drugs in End-Stage Kidney Disease

Andrew Wilcock; Sarah Charlesworth; Robert Twycross; Anne Waddington; Olivia Worthington; Fliss E M Murtagh; Jenny Beavis; Samuel King; Mary Mihalyo; Aleksandra Kotlinska-Lemieszek

doi:10.1016/j.jpainsymman.2017.08.014

Prescribing Non-Opioid Drugs in End-Stage Kidney Disease

J Pain Symptom Manage. 2017 Nov;54(5):776-787. doi: 10.1016/j.jpainsymman.2017.08.014. Epub 2017 Aug 24.

Authors

Affiliations

¹ University of Nottingham, Nottingham, United Kingdom. Electronic address: andrew.wilcock@nottingham.ac.uk.
² Nottingham University Hospitals, Nottingham, United Kingdom.
³ Oxford University, Oxford, United Kingdom.
⁴ Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom.
⁵ King's College London, Cicely Saunders Institute, London, United Kingdom.
⁶ Royal Melbourne Hospital, Parkville, Australia.
⁷ Saint Elizabeth Hospice, Ipswich, United Kingdom.
⁸ Mylan School of Pharmacy, Duquesne University, Pittsburgh, Pennsylvania, USA.
⁹ Karol Marcinkowski University of Medical Sciences and Hospice Palium, University Hospital of the Lord's Transfiguration, Poznan, Poland.

PMID: 28843456
DOI: 10.1016/j.jpainsymman.2017.08.014

Abstract

Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).

Publication types

Review

MeSH terms

Dialysis
Drug Prescriptions
Hospice Care
Humans
Kidney Failure, Chronic / drug therapy*
Palliative Care